Endogenous protease inhibitors in airway epithelial cells contribute to eosinophilic chronic rhinosinusitis

Hideaki Kouzaki, Koji Matsumoto, Hirotaka Kikuoka, Tomohisa Kato, Ichiro Tojima, Shino Shimizu, Hirohito Kita, Takeshi Shimizu

Research output: Contribution to journalReview article

25 Citations (Scopus)

Abstract

Rationale: Cystatin A and SPINK5 are endogenous protease inhibitors (EPIs) that may play key roles in epithelial barrier function. Objectives: To investigate the roles of EPIs in the pathogenesis of chronic rhinosinusitis (CRS). Methods: We examined the expression of cystatin A and SPINK5 in the nasal epithelial cells of patients with CRS. Additionally, the in vitro effects of recombinant EPIs on the secretion of the epithelialderived cytokines IL-25, IL-33, and thymic stromal lymphopoietin in airway epithelial cells, and the in vivo effects of recombinant EPIs in the nasal epithelium of mice exposed to multiple airborne allergens (MAA) were examined. Measurements and Main Results: Compared with control subjects and patients with noneosinophilic CRS, patients with eosinophilic CRS showed significantly lower protein and mRNA expression of cystatin A and SPINK5 in the nasal epithelium. Allergen-induced production of IL-25, IL-33, and thymic stromal lymphopoietininnormal humanbronchial epithelial cells was inhibited by treatment with recombinant cystatin A or SPINK5. Conversely, the production of these cytokines was increased when cystatin A or SPINK5 were knocked down with small interfering RNA. Chronic MAAexposure induced goblet cellmetaplasia and epithelial disruption inmousenasal epithelium and decreased the tissue expression and nasal lavage levels of cystatin A and SPINK5. Intranasal instillations of recombinant EPIs attenuated this MAA-induced pathology. Conclusions: Cystatin A and SPINK5 play an important role in protecting the airway epithelium from exogenous proteases. The preservation of EPIs may have a therapeutic benefit in intractable airway inflammation, such as eosinophilic CRS.

Original languageEnglish (US)
Pages (from-to)737-747
Number of pages11
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume195
Issue number6
DOIs
StatePublished - Mar 15 2017

Fingerprint

Cystatin A
Protease Inhibitors
Epithelial Cells
Allergens
Nasal Mucosa
Epithelium
Nasal Lavage
Cytokines
Nose
Small Interfering RNA
Peptide Hydrolases
Pathology
Inflammation
Messenger RNA

Keywords

  • Chronic rhinosinusitis
  • Cytokine
  • Endogenous protease inhibitor
  • Epithelial cell
  • Protease

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Endogenous protease inhibitors in airway epithelial cells contribute to eosinophilic chronic rhinosinusitis. / Kouzaki, Hideaki; Matsumoto, Koji; Kikuoka, Hirotaka; Kato, Tomohisa; Tojima, Ichiro; Shimizu, Shino; Kita, Hirohito; Shimizu, Takeshi.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 195, No. 6, 15.03.2017, p. 737-747.

Research output: Contribution to journalReview article

Kouzaki, Hideaki ; Matsumoto, Koji ; Kikuoka, Hirotaka ; Kato, Tomohisa ; Tojima, Ichiro ; Shimizu, Shino ; Kita, Hirohito ; Shimizu, Takeshi. / Endogenous protease inhibitors in airway epithelial cells contribute to eosinophilic chronic rhinosinusitis. In: American Journal of Respiratory and Critical Care Medicine. 2017 ; Vol. 195, No. 6. pp. 737-747.
@article{787aa884e0bf494fb079cb0f792ca5af,
title = "Endogenous protease inhibitors in airway epithelial cells contribute to eosinophilic chronic rhinosinusitis",
abstract = "Rationale: Cystatin A and SPINK5 are endogenous protease inhibitors (EPIs) that may play key roles in epithelial barrier function. Objectives: To investigate the roles of EPIs in the pathogenesis of chronic rhinosinusitis (CRS). Methods: We examined the expression of cystatin A and SPINK5 in the nasal epithelial cells of patients with CRS. Additionally, the in vitro effects of recombinant EPIs on the secretion of the epithelialderived cytokines IL-25, IL-33, and thymic stromal lymphopoietin in airway epithelial cells, and the in vivo effects of recombinant EPIs in the nasal epithelium of mice exposed to multiple airborne allergens (MAA) were examined. Measurements and Main Results: Compared with control subjects and patients with noneosinophilic CRS, patients with eosinophilic CRS showed significantly lower protein and mRNA expression of cystatin A and SPINK5 in the nasal epithelium. Allergen-induced production of IL-25, IL-33, and thymic stromal lymphopoietininnormal humanbronchial epithelial cells was inhibited by treatment with recombinant cystatin A or SPINK5. Conversely, the production of these cytokines was increased when cystatin A or SPINK5 were knocked down with small interfering RNA. Chronic MAAexposure induced goblet cellmetaplasia and epithelial disruption inmousenasal epithelium and decreased the tissue expression and nasal lavage levels of cystatin A and SPINK5. Intranasal instillations of recombinant EPIs attenuated this MAA-induced pathology. Conclusions: Cystatin A and SPINK5 play an important role in protecting the airway epithelium from exogenous proteases. The preservation of EPIs may have a therapeutic benefit in intractable airway inflammation, such as eosinophilic CRS.",
keywords = "Chronic rhinosinusitis, Cytokine, Endogenous protease inhibitor, Epithelial cell, Protease",
author = "Hideaki Kouzaki and Koji Matsumoto and Hirotaka Kikuoka and Tomohisa Kato and Ichiro Tojima and Shino Shimizu and Hirohito Kita and Takeshi Shimizu",
year = "2017",
month = "3",
day = "15",
doi = "10.1164/rccm.201603-0529OC",
language = "English (US)",
volume = "195",
pages = "737--747",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Endogenous protease inhibitors in airway epithelial cells contribute to eosinophilic chronic rhinosinusitis

AU - Kouzaki, Hideaki

AU - Matsumoto, Koji

AU - Kikuoka, Hirotaka

AU - Kato, Tomohisa

AU - Tojima, Ichiro

AU - Shimizu, Shino

AU - Kita, Hirohito

AU - Shimizu, Takeshi

PY - 2017/3/15

Y1 - 2017/3/15

N2 - Rationale: Cystatin A and SPINK5 are endogenous protease inhibitors (EPIs) that may play key roles in epithelial barrier function. Objectives: To investigate the roles of EPIs in the pathogenesis of chronic rhinosinusitis (CRS). Methods: We examined the expression of cystatin A and SPINK5 in the nasal epithelial cells of patients with CRS. Additionally, the in vitro effects of recombinant EPIs on the secretion of the epithelialderived cytokines IL-25, IL-33, and thymic stromal lymphopoietin in airway epithelial cells, and the in vivo effects of recombinant EPIs in the nasal epithelium of mice exposed to multiple airborne allergens (MAA) were examined. Measurements and Main Results: Compared with control subjects and patients with noneosinophilic CRS, patients with eosinophilic CRS showed significantly lower protein and mRNA expression of cystatin A and SPINK5 in the nasal epithelium. Allergen-induced production of IL-25, IL-33, and thymic stromal lymphopoietininnormal humanbronchial epithelial cells was inhibited by treatment with recombinant cystatin A or SPINK5. Conversely, the production of these cytokines was increased when cystatin A or SPINK5 were knocked down with small interfering RNA. Chronic MAAexposure induced goblet cellmetaplasia and epithelial disruption inmousenasal epithelium and decreased the tissue expression and nasal lavage levels of cystatin A and SPINK5. Intranasal instillations of recombinant EPIs attenuated this MAA-induced pathology. Conclusions: Cystatin A and SPINK5 play an important role in protecting the airway epithelium from exogenous proteases. The preservation of EPIs may have a therapeutic benefit in intractable airway inflammation, such as eosinophilic CRS.

AB - Rationale: Cystatin A and SPINK5 are endogenous protease inhibitors (EPIs) that may play key roles in epithelial barrier function. Objectives: To investigate the roles of EPIs in the pathogenesis of chronic rhinosinusitis (CRS). Methods: We examined the expression of cystatin A and SPINK5 in the nasal epithelial cells of patients with CRS. Additionally, the in vitro effects of recombinant EPIs on the secretion of the epithelialderived cytokines IL-25, IL-33, and thymic stromal lymphopoietin in airway epithelial cells, and the in vivo effects of recombinant EPIs in the nasal epithelium of mice exposed to multiple airborne allergens (MAA) were examined. Measurements and Main Results: Compared with control subjects and patients with noneosinophilic CRS, patients with eosinophilic CRS showed significantly lower protein and mRNA expression of cystatin A and SPINK5 in the nasal epithelium. Allergen-induced production of IL-25, IL-33, and thymic stromal lymphopoietininnormal humanbronchial epithelial cells was inhibited by treatment with recombinant cystatin A or SPINK5. Conversely, the production of these cytokines was increased when cystatin A or SPINK5 were knocked down with small interfering RNA. Chronic MAAexposure induced goblet cellmetaplasia and epithelial disruption inmousenasal epithelium and decreased the tissue expression and nasal lavage levels of cystatin A and SPINK5. Intranasal instillations of recombinant EPIs attenuated this MAA-induced pathology. Conclusions: Cystatin A and SPINK5 play an important role in protecting the airway epithelium from exogenous proteases. The preservation of EPIs may have a therapeutic benefit in intractable airway inflammation, such as eosinophilic CRS.

KW - Chronic rhinosinusitis

KW - Cytokine

KW - Endogenous protease inhibitor

KW - Epithelial cell

KW - Protease

UR - http://www.scopus.com/inward/record.url?scp=85015907259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015907259&partnerID=8YFLogxK

U2 - 10.1164/rccm.201603-0529OC

DO - 10.1164/rccm.201603-0529OC

M3 - Review article

C2 - 27779422

AN - SCOPUS:85015907259

VL - 195

SP - 737

EP - 747

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -